In this CE activity, expert faculty assess the use of newer therapies that demonstrate efficacy and safety in treating OSD and DED. They also review management strategies that improve outcomes for patients with MGD and blepharitis, as well as the selection of treatment regimens for real-world case presentations based on best practices.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/osdcme/dry-eye-therapeutics/20241202/optimizing-ocular-surface-and-eyelid-health-keeping-an-eye-on-the-prize/overview
- Start Date: 2024-11-30 06:00:00
- End Date: 2024-11-30 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- Commercial Support: Source: Tarsus Pharmaceuticals, Inc. - Amount: 12000.0 - Is Kind Support: False Source: Thea Pharma Inc. - Amount: 22500.0 - Is Kind Support: False Source: Viatris, Inc. - Amount: 8392.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest